Danaher | DHR - Los Gastos Financieros De La Deuda

Precio De Mercado
177.25
Cambio Diario
-1.32 -0.74%
Mensual
-5.29%
Anual
-10.09%
Q2 Expectativa
190.47




Los Gastos Financieros De La Deuda Cambio Fecha
Abbott USD 68M 26M 2026-03
Agilent USD 25M 2M 2025-12
Align Technology USD 2M 660K 2023-03
Becton, Dickinson and Co. USD 153M 2M 2025-12
Bio Techne USD 2.18M 173K 2025-06
Bio-Rad Laboratories USD 12.3M 100K 2025-09
Boston Scientific USD 90M 0 2026-03
Bruker USD 20M 4.3M 2025-09
Charles River Laboratories USD 23.78M 1.63M 2025-12
Danaher USD 63M 8M 2026-03
Dentsply International USD 22M 1000K 2025-12
Edwards Lifesciences USD 35.9M 2.7M 2025-12
ESCO Technologies USD 2.88M 2.25M 2025-12
Fortive USD 31M 56.4M 2025-12
Henry Schein USD 39M 1000K 2025-12
Illumina USD 25M 0 2025-09
Intuitive Surgical USD 20.11B 58.39B 2026-03
IQVIA Holdings USD 193M 4M 2025-12
Keysight Technologies USD 29M 1000K 2025-12
Laboratory Of America USD 55M 1000K 2025-12
Medtronic USD 181M 0 2025-12
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Quidel USD 5.68B 5.63B 2025-09
Repligen USD 5.5M 81K 2025-12
Revvity USD 23.51M 742K 2025-12
Roper Industries USD 93.3M 3.6M 2025-12
Stryker USD 157M 46.17B 2025-09
Thermo Fisher Scientific USD 354M 11M 2026-03
Waters USD 8.62M 18.02M 2025-12
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12